GlassScriptPhysician profile
Jon Erik Berguson
NPI 1073132411
$23,738.51
in general payments reported to CMS, 2019-2025
9 companies · $24K in 2025
The $24K reported for 2025 was more than what 92% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $23K · Travel and Lodging: $687 · Food and Beverage: $552.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $22,500.00 |
| Travel and Lodging | $686.72 |
| Food and Beverage | $551.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $20,024.00 | 2025 | |
| Smith+Nephew, INC. | $2,500.00 | 2025 | |
| Cgg Medical INC | $848.78 | 2025 | |
| Suvon Surgical LLC | $202.43 | 2025 | |
| Integra Lifesciences Corporation | $79.82 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Vertex Pharmaceuticals Incorporated | $24.91 | 2025 | |
| Globus Medical, INC. | $21.44 | 2025 | Anthem |
| Curonix LLC | $19.81 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Axogen | $17.32 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Berguson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.